JP2002051766A - Medium for detecting microorganisms - Google Patents
Medium for detecting microorganismsInfo
- Publication number
- JP2002051766A JP2002051766A JP2000239615A JP2000239615A JP2002051766A JP 2002051766 A JP2002051766 A JP 2002051766A JP 2000239615 A JP2000239615 A JP 2000239615A JP 2000239615 A JP2000239615 A JP 2000239615A JP 2002051766 A JP2002051766 A JP 2002051766A
- Authority
- JP
- Japan
- Prior art keywords
- medium
- yeast extract
- bacteria
- ekn
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
(57)【要約】
【課題】従来の酵母エキスが有する生育促進性能を更に
向上させると共に、培地の色が薄いため、菌数や菌の発
育性を判定し易いばかりでなく、外観色が見た目にも良
く、しかも安価で経済的な酵母エキスを含有する培地を
提供することにある。
【解決手段】トルラ酵母エキスを有効成分として含有す
ることを特徴とする微生物検出用培地。(57) [Summary] [PROBLEMS] To further improve the growth promoting performance of a conventional yeast extract, and because the color of the culture medium is light, not only is it easy to determine the number of bacteria and the growth of the bacteria, but also the appearance color is apparent. Another object of the present invention is to provide a medium containing a yeast extract, which is good and economical. A medium for detecting microorganisms, comprising a Torula yeast extract as an active ingredient.
Description
【0001】[0001]
【産業上の利用分野】本発明は、微生物検出用培地に関
し、特にトルラ酵母エキスを有効成分として含有する微
生物検出用培地に関するものである。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a culture medium for detecting microorganisms, and more particularly to a culture medium for detecting microorganisms containing a Torula yeast extract as an active ingredient.
【0002】[0002]
【従来技術】病院等における微生物検査では、感染症の
原因となる病原菌を検出するため、検査材料からの微生
物の分離培養や増殖培養を行わなければならない。特に
感染症の病像が複雑で多岐にわたり、臨床所見からの病
原菌の推定が困難になりつつある現在、微生物検査によ
る迅速かつ正確な検出結果は更に重要性を増している。2. Description of the Related Art In a microorganism test at a hospital or the like, in order to detect a pathogenic bacterium causing an infectious disease, it is necessary to carry out separation culture or growth culture of a microorganism from a test material. In particular, at present, the pathology of infectious diseases is complicated and diversified, and it is becoming difficult to estimate pathogenic bacteria from clinical findings. Therefore, rapid and accurate detection results by microbial tests have become even more important.
【0003】この微生物検査において病原菌の特定を行
う場合、一般に寒天平板培地に検体を塗布し分離培養を
行う。使用する培地により、目的菌が発育した集落の形
状、色および集落周囲の培地の色の変化等に差が生じ
る。これを利用して雑多に発育した集落より目的菌をス
クリーニングして生化学的性状検査等に移行する。[0003] When a pathogen is identified in this microbial test, a specimen is generally applied to an agar plate medium and separated and cultured. Depending on the culture medium used, differences occur in the shape and color of the colony in which the target bacterium has grown, and in the color change of the culture medium around the colony. Using this, the target bacterium is screened from miscellaneously developed colonies, and the process is shifted to biochemical property inspection and the like.
【0004】ところで、微生物を培養する培地の窒素源
としては、ミルクカゼイン、ゼラチン、大豆タンパク質
などのタンパク質をトリプシン、ペプシン、パパインな
どの酵素で加水分解して調製されたペプトンが用いられ
ていた。しかしながら、窒素源としてペプトンを用いた
としても、栄養要求性の高い微生物では、生育が十分で
ない場合があった(特開平7−265066号公報)。[0004] As a nitrogen source in a medium for culturing microorganisms, peptone prepared by hydrolyzing proteins such as milk casein, gelatin and soybean protein with enzymes such as trypsin, pepsin and papain has been used. However, even when peptone is used as a nitrogen source, there is a case where a microorganism having high auxotrophy does not grow sufficiently (Japanese Patent Application Laid-Open No. Hei 7-265066).
【0005】このため、窒素源としては、微生物の生育
促進物質を豊富に含む酵母エキスが用いられている。酵
母エキスとしては、ビール酵母エキスやパン酵母エキス
が知られている。因みに、ビール酵母エキスは、ビール
発酵後の余剰酵母をエキス化したものであり、パン酵母
は、糖蜜発酵で培養したサッカロミセス属酵母を原料に
エキス化したものである。[0005] Therefore, as a nitrogen source, a yeast extract rich in a substance for promoting the growth of microorganisms is used. As yeast extracts, beer yeast extract and baker's yeast extract are known. Incidentally, the brewer's yeast extract is obtained by extracting excess yeast after beer fermentation, and the baker's yeast is obtained by extracting saccharomyces yeast cultured by molasses fermentation as a raw material.
【0006】[0006]
【発明が解決しようとする課題】しかしながら、これら
の酵母エキスを用いた場合でも、確かに微生物の生育促
進性能は改善されるものの、サンプルが少量の場合には
陽性や陰性の判定が困難な場合があり、更に改善された
培地の出現が強く望まれていた。従って本発明は、この
ような従来の課題に着目してなされたものであって、従
来の酵母エキスが有する生育促進性能を更に向上させる
と共に、従来品に比べて溶液の色が薄く、外観色が見た
目にも良く、しかも安価で経済的な酵母エキスを含有す
る培地を提供することにある。However, even when these yeast extracts are used, the growth promotion performance of microorganisms is certainly improved, but when the sample is small, it is difficult to judge positive or negative. Therefore, the appearance of a further improved medium has been strongly desired. Therefore, the present invention has been made in view of such conventional problems, and further enhances the growth promoting performance of the conventional yeast extract, the color of the solution is lighter than the conventional product, and the appearance color An object of the present invention is to provide a culture medium containing a yeast extract which is good in appearance and is inexpensive and economical.
【0007】[0007]
【課題を解決するための手段】本発明者らは、従来の酵
母エキスに代わる新たな酵母エキスを鋭意探索した結
果、カンジダ属の酵母を糖蜜原料に培養しエキス化した
トルラ酵母エキスが上記課題を解決できることを見出
し、本発明を完成した。Means for Solving the Problems As a result of the present inventors diligently searching for a new yeast extract that replaces the conventional yeast extract, a torula yeast extract obtained by culturing Candida yeast as a molasses raw material and extracting the same was obtained as described above. Have been found, and the present invention has been completed.
【0008】本発明の上記の課題は、トルラ酵母エキス
を有効成分として含有する微生物検出用培地により達成
された。以下、本発明について更に詳細に説明する。[0008] The above object of the present invention has been achieved by a microorganism detection medium containing Torula yeast extract as an active ingredient. Hereinafter, the present invention will be described in more detail.
【0009】本発明に使用するトルラ酵母エキスは、ガ
ンジダ属の酵母を糖蜜原料を培養しエキス化したもので
ある。この酵母エキスは、従来用いていたビール酵母エ
キスやパン酵母エキスに比べて5’−イノシン酸、5’
−グアニル酸およびオリゴヌクレオチドの含有量が高い
ことで知られている。The torula yeast extract used in the present invention is obtained by culturing a molasses raw material from yeast of the genus Gandida and extracting it. This yeast extract has 5′-inosinic acid and 5 ′ as compared with conventionally used beer yeast extract and baker's yeast extract.
-It is known for its high content of guanylic acid and oligonucleotides.
【0010】本発明においては、トルラ酵母エキスの含
有量を培地全量に対して0.001〜0.01g/m
l、好ましくは0.005〜0.01g/mlの範囲と
なるように含有させる。トルラ酵母エキスの含有量が
0.001g/ml未満になると、微生物の生育促進性
能を向上させることができず、逆に0.01g/mlを
超えると、高価なものになり、経済性に劣る。In the present invention, the content of the yeast extract is 0.001 to 0.01 g / m 2 based on the total amount of the medium.
1, preferably in the range of 0.005 to 0.01 g / ml. When the content of the torula yeast extract is less than 0.001 g / ml, the ability to promote the growth of microorganisms cannot be improved. Conversely, when the content exceeds 0.01 g / ml, it becomes expensive and inferior in economy. .
【0011】本発明の微生物検出用培地は、液体、半流
動、固形のいずれの形態もとりうるが、検出のし易さ等
の観点から、固形培地が好ましく、より好ましくは平板
固形培地の形態である。固形培地の固化剤としては、寒
天、カラギーナン、アガロースなど通常使用されている
ものが挙げられる。本発明に使用しうる培地としては、
微生物が増殖できる限り、公知の培地の中から適宜選択
することができる。このような培地の具体例としては、
ハートインフュージョン培地、トリプトソイ培地、マン
ニット食塩培地、スタピロコッカス培地が挙げられる。The medium for detecting microorganisms of the present invention may be in any form of liquid, semi-fluid, or solid. However, from the viewpoint of easy detection, a solid medium is preferable, and more preferably, a plate solid medium. is there. Examples of the solidifying agent for the solid medium include those commonly used such as agar, carrageenan, and agarose. As the medium that can be used in the present invention,
As long as the microorganism can grow, it can be appropriately selected from known media. Specific examples of such a medium include:
Examples include a heart infusion medium, a tryptic soy medium, a mannitol salt medium, and a stapilococcus medium.
【0012】本発明の培地組成は、実質的にトルラ酵母
エキス、ペプトン、ブドウ糖、寒天および精製水を含む
ものである。トルラ酵母エキス、ペプトン、ブドウ糖の
配合割合は、従来用いられている濃度を用いることがで
きるが、通常精製水1000mlに対してトルラ酵母エ
キス1.0〜10.0g、好ましくは2.0〜6.0
g、ペプトン2.0〜20.0g、好ましくは5.0〜
15g、ブドウ糖0.5〜30g、好ましくは1〜20
gである。The medium composition of the present invention contains substantially Torula yeast extract, peptone, glucose, agar and purified water. The torla yeast extract, peptone, and glucose can be used in the proportions conventionally used, but usually 1.0 to 10.0 g, preferably 2.0 to 6 g of torula yeast extract per 1000 ml of purified water. .0
g, peptone 2.0-20.0 g, preferably 5.0-2.0.
15 g, glucose 0.5 to 30 g, preferably 1 to 20
g.
【0013】固形剤(寒天など)は、使用する培地の所
望の硬度(固体、半流動)により任意に設定することが
できる。本発明の培地は、これらの成分を溶解した状態
で通常の酸または塩基を必要に応じて加えpHを5.5
〜9.0の範囲に調整することにより微生物の検出率を
更に向上させることができる。The solid agent (eg, agar) can be arbitrarily set depending on the desired hardness (solid, semi-fluid) of the medium to be used. The medium of the present invention is prepared by dissolving these components and adding a normal acid or base as needed to adjust the pH to 5.5.
By adjusting the ratio to the range of ~ 9.0, the detection rate of microorganisms can be further improved.
【0014】本発明の微生物検出用培地を、固形培地と
して用いる場合には、例えばブドウ球菌の存在の確認を
目的とする検査用サンプルの適当量を、予め調製した本
発明の微生物検出用培地の固形培地上にサンプリング
し、適当な条件下で培養を行い、発生したブドウ球菌の
コロニーの存否から、ブドウ球菌の存在を確認する。When the culture medium for detecting microorganisms of the present invention is used as a solid medium, for example, an appropriate amount of a test sample for confirming the presence of staphylococci is prepared by adding an appropriate amount of a test medium prepared in advance for the culture medium for detecting microorganisms of the present invention. Sampling is performed on a solid medium, cultured under appropriate conditions, and the presence or absence of the generated staphylococcal colonies is confirmed for the presence of staphylococci.
【0015】本発明には、特に必要とされないが、pH
指示薬を用いることにより、試験試料が少量でも反応の
陽性や陰性が明瞭に判定できるようにすることができ
る。このようなpH指示薬としては、特に制限はない
が、ブロムチモールブルー、フェノールレッド、ブロム
クレゾールパープル、クレゾールレッド、ブロムフェノ
ールレッドが挙げられるが、中でもブロムチモールブル
ーが好ましい。Although not particularly required for the present invention, pH
By using the indicator, it is possible to clearly determine whether the reaction is positive or negative even if the test sample is small. Such pH indicators are not particularly limited, and include bromthymol blue, phenol red, bromcresol purple, cresol red, and bromphenol red, with bromthymol blue being preferred.
【0016】[0016]
【発明の効果】本発明の微生物検出用培地は、従来の酵
母エキスが有する微生物の生育促進性能を更に向上させ
ることができ、更に従来品に比べて溶液の色が薄く、外
観色が見た目にも良い。従って、本発明の微生物検出用
培地によれば、サンプルが少量の場合でも陽性や陰性の
判定を高い精度で行うことができる。また、本発明の微
生物検出用培地は、従来用いていたビール酵母エキスや
パン酵母エキスに比べて安価なトルラ酵母エキスを用い
るため、経済的にも有利である。EFFECTS OF THE INVENTION The microorganism detection medium of the present invention can further improve the growth promotion performance of microorganisms of the conventional yeast extract, and furthermore, the color of the solution is lighter than that of the conventional product, and the appearance color is visually apparent. Is also good. Therefore, according to the microorganism detection medium of the present invention, the determination of positive or negative can be performed with high accuracy even when the sample is small. In addition, the medium for detecting microorganisms of the present invention is economically advantageous because it uses a less expensive torula yeast extract as compared to conventionally used beer yeast extract and baker's yeast extract.
【0017】[0017]
【実施例】以下、実施例によって本発明を更に詳細に説
明するが、本発明はこれによって限定されるものではな
い。EXAMPLES The present invention will be described in more detail with reference to the following Examples, but it should not be construed that the present invention is limited thereto.
【0018】実施例1.標準寒天培地を用いた微生物の
検出 表1に示した培地成分を精製水1000mlに溶解し、
121℃で20分間滅菌後、シャーレに20mlを注入
し、ハートブイヨン培地で前培養した菌液を10倍連続
希釈してそれぞれ10-6、10-7とした菌株を混釈法で
1ml接種し、培地が凝固しないうちに混合して均一に
して凝固後、37℃で20時間培養し、菌数を測定し
た。対照として従来の酵母エキスを用いた培地で菌数を
比較した。その結果を表2〜表6に示す。表に示すよう
に、本発明品は、従来品に比べて、菌数が多いため、微
生物の判定が容易となる。Embodiment 1 FIG. Detection of microorganisms using standard agar medium The medium components shown in Table 1 were dissolved in 1000 ml of purified water,
After sterilization at 121 ° C. for 20 minutes, 20 ml of the mixture was poured into a Petri dish, and 1 ml of the bacterial solution precultured in a heart bouillon medium was diluted 10-fold to 10 −6 and 10 −7 , respectively, and inoculated with 1 ml by a pour method. After the medium was mixed and coagulated before coagulation, the cells were coagulated and cultured at 37 ° C. for 20 hours to measure the number of bacteria. As a control, the number of bacteria was compared in a medium using a conventional yeast extract. The results are shown in Tables 2 to 6. As shown in the table, the product of the present invention has a larger number of bacteria than the conventional product, so that determination of microorganisms becomes easier.
【0019】表1 標準寒天培地の組成 ──────────── 酵母エキス 2.5g トリプトン 5g ブドウ糖 1g 寒天 15g pH 7.1±Table 1 Composition of standard agar medium 酵母 Yeast extract 2.5 g Tryptone 5 g Glucose 1 g Agar 15 g pH 7.1 ±
【0020】 表2 ────────────────────────────── 菌名 Staphylococcus aureus EKN-1 接種菌液 10-6 10-7 回数 1 2 平均 1 2 平均 従来品 125 152 139 7 12 10 新規品 136 160 148 14 18 16[0020] Table 2 ────────────────────────────── bacteria name Staphylococcus aureus EKN-1 inoculum 10 -6 10 - 7 times 1 2 Average 1 2 Average Conventional 125 125 139 7 12 10 New 136 160 148 14 18 16
【0021】 表3 ────────────────────────────── 菌名 Staphylococcus aureus EKN-2 接種菌液 10-6 10-7 回数 1 2 平均 1 2 平均 従来品 84 87 86 6 8 7 新規品 90 98 94 8 10 9[0021] Table 3 ────────────────────────────── bacteria name Staphylococcus aureus EKN-2 inoculum 10 -6 10 - 7 times 1 2 average 1 2 average Conventional product 84 87 86 6 8 7 New product 90 98 94 8 10 9
【0022】 表4 ────────────────────────────── 菌名 Proteus vulgaris EKN-1 接種菌液 10-6 10-7 回数 1 2 平均 1 2 平均 従来品 186 196 191 15 19 17 新規品 194 197 196 22 24 23[0022] Table 4 ────────────────────────────── bacteria name Proteus vulgaris EKN-1 inoculum 10 -6 10 - 7 times 1 2 Average 1 2 Average Conventional product 186 196 191 15 19 17 New product 194 197 196 22 22 23
【0023】 表5 ────────────────────────────── 菌名 Proteus vulgaris EKN-2 接種菌液 10-6 10-7 回数 1 2 平均 1 2 平均 従来品 114 101 108 7 11 9 新規品 118 110 114 10 16 13[0023] Table 5 ────────────────────────────── bacteria name Proteus vulgaris EKN-2 inoculum 10 -6 10 - 7 times 1 2 average 1 2 average Conventional 114 114 108 7 11 9 New 118 118 114 10 16 13
【0024】 表6 ────────────────────────────── 菌名 Escherichia coli EKN-1 接種菌液 10-6 10-7 回数 1 2 平均 1 2 平均 従来品 114 101 108 7 11 9 新規品 118 104 111 10 12 11[0024] Table 6 ────────────────────────────── bacteria name Escherichia coli EKN-1 inoculum 10 -6 10 - 7 times 1 2 Average 1 2 Average Conventional 114 114 108 7 11 9 New 118 118 111 111 10 12 11
【0025】実施例2.TCBS寒天培地を用いた微生
物の検出 表7に示した培地成分を精製水1000mLに溶解し、
121℃で20分間滅菌後、シャーレに注入して常法に
より固化した培地に、ハートブイヨン培地で前培養した
菌液を10-1〜10-6まで10倍連続希釈した菌株を
ミスラ法で接種し、37℃で20時間培養後、菌の発育
性、菌数およびコロニーの大きさを評価した。対照とし
て従来の酵母エキスを用いた培地で菌の発育性、菌数お
よびコロニーの大きさを比較した。その結果を表8〜表
16に示す。表に示すように、本発明品は、菌数および
コロニーの大きさとも、従来品より優れるため、判定が
容易である。Embodiment 2 FIG. Detection of microorganisms using TCBS agar medium The medium components shown in Table 7 were dissolved in 1000 mL of purified water,
After sterilization at 121 ° C for 20 minutes, the culture solution injected into a petri dish and solidified by a conventional method is inoculated with a strain obtained by serially diluting a bacterial solution pre-cultured with a heart bouillon medium to 10 -1 to 10 -6 by 10 times in a Misura method. After culturing at 37 ° C. for 20 hours, the growth of bacteria, the number of bacteria and the size of colonies were evaluated. As a control, the growth of bacteria, the number of bacteria and the size of colonies were compared in a medium using a conventional yeast extract. Tables 8 to 16 show the results. As shown in the table, the product of the present invention is superior to the conventional product in both the number of bacteria and the size of the colonies, and therefore, the determination is easy.
【0026】表7 TCBS寒天培地の組成 ──────────────── 酵母エキス 5g ぺプトン 10g 白糖 20g チオ硫酸ナトリウム 7g クエン酸ナトリウム 10g コール酸ナトリウム 3g ウシ胆汁末 5g 塩化ナトリウム 10g クエン酸鉄 1g ブロムチモールブルー 0.04g チモールブルー 0.04g 寒天 15g pH 8.8±Table 7 Composition of TCBS agar medium ──────────────── Yeast extract 5 g Peptone 10 g Sucrose 20 g Sodium thiosulfate 7 g Sodium citrate 10 g Sodium cholate 3 g Bovine bile powder 5 g Sodium chloride 10 g Iron citrate 1 g Bromthymol blue 0.04 g Thymol blue 0.04 g Agar 15 g pH 8.8 ±
【0027】 表8 ────────────────────────────────── 菌名 Vibrio cholerae EKN-1 接種菌液 10-5 10-6 コロニー 従来品 + 4 1.0mm 新規品 + 11 1.1mm Table 8 ────────────────────────────────── Bacterial name Vibrio cholerae EKN-1 inoculated bacterial solution 10 -5 10 -6 colony Conventional product + 4 1.0 mm New product + 11 1.1 mm
【0028】 表9 ────────────────────────────────── 菌名 Vibrio cholerae EKN-2 接種菌液 10-5 10-6 コロニー 従来品 + − 1.0mm 新規品 + 3 1.1mm Table 9 ────────────────────────────────── Bacterial name Vibrio cholerae EKN-2 inoculated bacterial solution 10 -5 10 -6 colony Conventional product +-1.0mm New product + 3 1.1mm
【0029】 表10 ────────────────────────────────── 菌名 Vibrio cholerae EKN-3 接種菌液 10-5 10-6 コロニー 従来品 + 2 1.8mm 新規品 + 7 1.9mm Table 10 菌 Bacterial name Vibrio cholerae EKN-3 Inoculated bacterial solution 10 -5 10 -6 colony Conventional product +2 1.8 mm New product +7 1.9 mm
【0030】 表11 ────────────────────────────────── 菌名 Vibrio cholerae EKN-4 接種菌液 10-5 10-6 コロニー 従来品 + 4 1.1mm 新規品 + 8 1.2mm Table 11 ────────────────────────────────── Bacteria name Vibrio cholerae EKN-4 inoculated bacterial solution 10 -5 10 -6 colony Conventional product + 4 1.1mm New product + 8 1.2mm
【0031】 表12 ────────────────────────────────── 菌名 Vibrio parahaemolyticus EKN-1 接種菌液 10-5 10-6 コロニー 従来品 + 1 1.1mm 新規品 + 5 1.2mm Table 12 ────────────────────────────────── Bacterial name Vibrio parahaemolyticus EKN-1 inoculated bacterial solution 10 -5 10 -6 colony Conventional product + 1 1.1mm New product + 5 1.2mm
【0032】 表13 ────────────────────────────────── 菌名 Vibrio parahaemolyticus EKN-2 接種菌液 10-5 10-6 コロニー 従来品 + 4 1.1mm 新規品 + 10 1.2mm Table 13 菌 Bacterial name Vibrio parahaemolyticus EKN-2 inoculated bacterial solution 10 -5 10 -6 colony Conventional product + 4 1.1mm New product + 10 1.2mm
【0033】 表14 ────────────────────────────────── 菌名 Vibrio parahaemolyticus EKN-3 接種菌液 10-5 10-6 コロニー 従来品 + 6 1.1mm 新規品 + 10 1.2mm Table 14 菌 Bacteria name Vibrio parahaemolyticus EKN-3 Inoculated bacterial solution 10 -5 10 -6 colony Conventional product + 6 1.1 mm New product + 10 1.2 mm
【0034】 表15 ────────────────────────────────── 菌名 Vibrio alginolyticus EKN-1 接種菌液 10-5 10-6 コロニー 従来品 − − 微小mm 新規品 11 4 2.2mm Table 15 ────────────────────────────────── Bacteria name Vibrio alginolyticus EKN-1 inoculated bacterial solution 10 -5 10 -6 colony Conventional product--Fine mm New product 11 4 2.2 mm
【0035】 表16 ────────────────────────────────── 菌名 Vibrio alginolyticus EKN-2 接種菌液 10-5 10-6 コロニー 従来品 12 − 2.1mm 新規品 14 2 2.2mm Table 16 ────────────────────────────────── Bacterial name Vibrio alginolyticus EKN-2 inoculated bacterial solution 10 -5 10 -6 colony Conventional product 12-2.1 mm New product 14 2 2.2 mm
【0036】実施例3.ガンジダGS寒天培地を用いた
微生物の検出 表17に示した培地成分を用いた以外は、実施例2と全
く同様にして菌の発育性、菌数およびコロニーの大きさ
を評価した。その結果を表18〜表25に示す。表に示
すように、本発明品は、従来品に比べて、菌数およびコ
ロニーの大きさとも勝るため、判定が容易となる。Embodiment 3 FIG. Detection of microorganisms using Gandida GS agar medium Except for using the medium components shown in Table 17, the bacterial growth, the number of bacteria, and the size of colonies were evaluated in exactly the same manner as in Example 2. The results are shown in Tables 18 to 25. As shown in the table, the product of the present invention is superior to the conventional product in both the number of bacteria and the size of the colonies, so that the determination is easy.
【0037】表17 ガンジダGS寒天培地の組成 ──────────────── 酵母エキス 4.5g ぺプトン 10g ブドウ糖 20g ニトロフラン誘導体 0.5g 寒天 15g pH 6.0±Table 17 Composition of Gandida GS agar medium ──────────────── Yeast extract 4.5 g Peptone 10 g Glucose 20 g Nitrofuran derivative 0.5 g Agar 15 g pH 6.0 ±
【0038】 表18 ────────────────────────────── 菌名 candido albicans EKN-1 接種菌液 10-5 10-6 コロニー 従来品 3 2 1.5mm 新規品 8 6 1.6mm[0038] Table 18 ────────────────────────────── bacteria name candido albicans EKN-1 inoculum 10 -5 10 - 6 colonies Conventional product 3 2 1.5 mm New product 8 6 1.6 mm
【0039】 表19 ────────────────────────────── 菌名 candido albicans EKN-2 接種菌液 10-5 10-6 コロニー 従来品 4 − 1.1mm 新規品 6 4 1.2mm[0039] Table 19 ────────────────────────────── bacteria name candido albicans EKN-2 inoculum 10 -5 10 - 6 colonies Conventional 4-1.1mm New 6 4 1.2mm
【0040】 表20 ────────────────────────────── 菌名 candido albicans EKN-3 接種菌液 10-5 10-6 コロニー 従来品 12 1 1.2mm 新規品 16 4 1.3mm[0040] Table 20 ────────────────────────────── bacteria name candido albicans EKN-3 inoculum 10 -5 10 - 6 colonies Conventional 12 1 1.2mm New 16 4 1.3mm
【0041】 表21 ────────────────────────────── 菌名 candido albicans EKN-3 接種菌液 10-5 10-6 コロニー 従来品 12 1 1.2mm 新規品 15 4 1.3mm[0041] Table 21 ────────────────────────────── bacteria name candido albicans EKN-3 inoculum 10 -5 10 - 6 colonies Conventional 12 1 1.2mm New 15 4 1.3mm
【0042】 表22 ────────────────────────────── 菌名 candido albicans EKN-4 接種菌液 10-5 10-6 コロニー 従来品 + 3 1.0mm 新規品 + 6 1.1mm[0042] Table 22 ────────────────────────────── bacteria name candido albicans EKN-4 inoculum 10 -5 10 - 6 colonies Conventional product + 3 1.0mm New product + 6 1.1mm
【0043】 表23 ────────────────────────────── 菌名 candido albicans EKN-5 接種菌液 10-5 10-6 コロニー 従来品 6 − 2.0mm 新規品 9 3 2.1mm[0043] Table 23 ────────────────────────────── bacteria name candido albicans EKN-5 inoculum 10 -5 10 - 6 colonies Conventional product 6-2.0mm New product 9 3 2.1mm
【0044】 表24 ────────────────────────────── 菌名 candido albicans EKN-6 接種菌液 10-5 10-6 コロニー 従来品 14 2 1.1mm 新規品 18 7 1.2mm[0044] Table 24 ────────────────────────────── bacteria name candido albicans EKN-6 inoculum 10 -5 10 - 6 colonies Conventional product 14 2 1.1mm New product 18 7 1.2mm
【0045】 表25 ────────────────────────────── 菌名 candido pseudotropicalis EKN-1 接種菌液 10-5 10-6 コロニー 従来品 − − 1.3mm 新規品 6 2 1.4mm[0045] Table 25 ────────────────────────────── bacteria name candido pseudotropicalis EKN-1 inoculum 10 -5 10 - 6 colonies Conventional product--1.3 mm New product 6 2 1.4 mm
【0046】 表26 ────────────────────────────── 菌名 candido glabrata EKN-1 接種菌液 10-5 10-6 コロニー 従来品 4 − 1.5mm 新規品 8 3 1.6mm[0046] Table 26 ────────────────────────────── bacteria name candido glabrata EKN-1 inoculum 10 -5 10 - 6 colonies Conventional product 4-1.5 mm New product 8 3 1.6 mm
【0047】実施例4.トルラ酵母エキスを用いた場合
の培地の色 表27に示した培地成分を精製水1000mLに溶解
し、121℃で20分間滅菌後、培地の溶液の色を日立
製作所製の分光光度計を用いて420nmで測定した。
対照として従来の酵母エキスを用いて同様に溶液の色を
測定した。その結果、従来品は0.480であったのに
対し、本発明品は0.353であった。この結果に示す
ように、本発明品は、従来品に比べて溶液の色が薄いた
め、菌数や菌の発育性を判定し易いばかりでなく、外観
色が見た目にも良い。Embodiment 4 FIG. Color of medium when torula yeast extract is used The medium components shown in Table 27 are dissolved in 1000 mL of purified water, sterilized at 121 ° C. for 20 minutes, and the color of the medium solution is measured using a spectrophotometer manufactured by Hitachi, Ltd. Measured at 420 nm.
The color of the solution was similarly measured using a conventional yeast extract as a control. As a result, the value of the conventional product was 0.480, while that of the product of the present invention was 0.353. As shown in the results, the product of the present invention has a lighter solution color than the conventional product, so that not only the number of bacteria and the growth of bacteria can be easily determined, but also the appearance color is good.
【0048】表27 寒天培地の組成 ──────────────── 酵母エキス 5g ぺプトン 15g ブドウ糖 5g チオグリコール酸ナトリウム 0.5g L−シスチン 0.5g 塩化ナトリウム 2.5g pH 7.1±Table 27 Composition of agar medium 酵母 yeast extract 5 g peptone 15 g glucose 5 g sodium thioglycolate 0.5 g L-cystine 0.5 g sodium chloride 5g pH 7.1 ±
【0049】[0049]
Claims (3)
ることを特徴とする微生物検出用培地。1. A medium for detecting microorganisms, comprising a Torula yeast extract as an active ingredient.
0.01g/mlの範囲である請求項1記載の微生物検
出用培地。2. The content of torula yeast extract is 0.001 to 0.001.
The medium for detecting microorganisms according to claim 1, wherein the medium is in a range of 0.01 g / ml.
2記載の微生物検出用培地。3. The microorganism detection medium according to claim 1, which is in the form of a plate solid medium.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000239615A JP4544714B2 (en) | 2000-08-08 | 2000-08-08 | Microbe detection medium |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000239615A JP4544714B2 (en) | 2000-08-08 | 2000-08-08 | Microbe detection medium |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002051766A true JP2002051766A (en) | 2002-02-19 |
| JP4544714B2 JP4544714B2 (en) | 2010-09-15 |
Family
ID=18731125
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000239615A Expired - Fee Related JP4544714B2 (en) | 2000-08-08 | 2000-08-08 | Microbe detection medium |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4544714B2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017217532A1 (en) * | 2016-06-16 | 2017-12-21 | 株式会社明治 | Lactobacillus fermentation promoter |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0662834A (en) * | 1992-05-22 | 1994-03-08 | Becton Dickinson & Co | Transporting medium relating to microbial specimen containing leukocytolytic agent of white blood cell |
| JPH0678749A (en) * | 1992-07-13 | 1994-03-22 | Terumo Corp | Microbe detecting instrument |
| JPH08173190A (en) * | 1994-12-28 | 1996-07-09 | Showa Shell Sekiyu Kk | Test method for the presence of microorganisms and test kit used for the test method |
| JPH10179084A (en) * | 1996-12-27 | 1998-07-07 | Sapporo Breweries Ltd | Production method of yeast extract |
| JPH11113562A (en) * | 1997-10-09 | 1999-04-27 | Konica Corp | Detection of microorganism, device for detecting microorganism and plate for detecting microorganism |
| JP2000069994A (en) * | 1998-08-28 | 2000-03-07 | Konica Corp | Detecting of microorganism and microorganism detecting system |
-
2000
- 2000-08-08 JP JP2000239615A patent/JP4544714B2/en not_active Expired - Fee Related
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0662834A (en) * | 1992-05-22 | 1994-03-08 | Becton Dickinson & Co | Transporting medium relating to microbial specimen containing leukocytolytic agent of white blood cell |
| JPH0678749A (en) * | 1992-07-13 | 1994-03-22 | Terumo Corp | Microbe detecting instrument |
| JPH08173190A (en) * | 1994-12-28 | 1996-07-09 | Showa Shell Sekiyu Kk | Test method for the presence of microorganisms and test kit used for the test method |
| JPH10179084A (en) * | 1996-12-27 | 1998-07-07 | Sapporo Breweries Ltd | Production method of yeast extract |
| JPH11113562A (en) * | 1997-10-09 | 1999-04-27 | Konica Corp | Detection of microorganism, device for detecting microorganism and plate for detecting microorganism |
| JP2000069994A (en) * | 1998-08-28 | 2000-03-07 | Konica Corp | Detecting of microorganism and microorganism detecting system |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017217532A1 (en) * | 2016-06-16 | 2017-12-21 | 株式会社明治 | Lactobacillus fermentation promoter |
| CN109312292A (en) * | 2016-06-16 | 2019-02-05 | 株式会社明治 | Lactic acid bacteria fermentation accelerator |
| CN109312292B (en) * | 2016-06-16 | 2022-10-14 | 株式会社明治 | Lactic acid bacteria fermentation promoter |
Also Published As
| Publication number | Publication date |
|---|---|
| JP4544714B2 (en) | 2010-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wesley Catlin | Nutritional profiles of Neisseria gonorrhoeae, Neisseria meningitidis, and Neisseria lactamica in chemically defined media and the use of growth requirements for gonococcal typing | |
| US6387651B1 (en) | Comparative phenotype analysis of two or more microorganisms using a plurality of substrates within a microwell device | |
| CN102449137B (en) | Mycobacterial culture medium and method for culturing including mycobacteria of the Mycobacterium tuberculosis complex | |
| EP1600514B1 (en) | Selective culture medium for the isolation and/or detection of species in the streptococcus genus | |
| Loeb | Ferrochelatase activity and protoporphyrin IX utilization in Haemophilus influenzae | |
| AU732841B2 (en) | Media for the culturing and specific identification of various candida species, and analytical processes | |
| CN110044881A (en) | A kind of detection kit and its application method of enzymatic assays creatinine | |
| US20040235012A1 (en) | Method of detecting antibiotic resistance in microorganisms | |
| CN101643713A (en) | Legionnella selective separation medium | |
| JP2002051766A (en) | Medium for detecting microorganisms | |
| JP2001161396A (en) | How to identify microorganisms in a sample | |
| JP2879698B2 (en) | Medium for detecting coliforms | |
| US4217411A (en) | Novel enrichments for blood culture media | |
| JP2001128666A (en) | Chromogen indicating medium containing blood or hemin | |
| Brenwald et al. | Selective medium for isolating Arcanobacterium haemolyticum | |
| EP2205976A2 (en) | Biochemical test for confirming the presence of<i>l. monocytogenes</i> | |
| JP3380956B2 (en) | Staphylococcus aureus detection medium | |
| CN119351275B (en) | A strain of fermented Lactobacillus mucilaginosus producing γ-aminobutyric acid and its application | |
| RU2387714C2 (en) | Method of preparing growing medium for revealing blue pus bacillus | |
| JP5730304B2 (en) | Novel nitroreductase enzyme substrate | |
| RU2283348C1 (en) | Nutrient medium and preliminary identification of escherichia coli | |
| Hinton et al. | Colorimetric determination of human albumin | |
| CN102703572A (en) | Method for detecting mycobacterium tuberculosis drug sensitivity and culture medium | |
| JP2013500038A (en) | Novel nitroreductase enzyme substrate | |
| US7229812B2 (en) | Modified sarcosine oxidase, process for producing the same and reagent composition using the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070724 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100506 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20100628 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20100629 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130709 Year of fee payment: 3 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 4544714 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130709 Year of fee payment: 3 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |